|
BTN2A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.475600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.748600E-01 |
| Normal-vs-Stage2 |
2.980500E-02 |
| Normal-vs-Stage3 |
1.382250E-03 |
| Normal-vs-Stage4 |
5.010400E-02 |
| Stage1-vs-Stage2 |
8.171800E-02 |
| Stage1-vs-Stage3 |
5.380000E-03 |
| Stage1-vs-Stage4 |
2.024000E-01 |
| Stage2-vs-Stage3 |
7.911200E-01 |
| Stage2-vs-Stage4 |
6.790000E-01 |
| Stage3-vs-Stage4 |
4.336600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.736190E-02 |
| Normal-vs-AfricanAmerican |
8.883200E-01 |
| Normal-vs-Asian |
4.756800E-01 |
| Caucasian-vs-AfricanAmerican |
2.123800E-01 |
| Caucasian-vs-Asian |
2.570100E-02 |
| AfricanAmerican-vs-Asian |
5.350000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.776100E-02 |
| Normal-vs-Female |
2.485600E-02 |
| Male-vs-Female |
7.860400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.226800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.173700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.987300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.794200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.236440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.855700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.223200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.365000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.447200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.203500E-04 |
| Classical-VS-Follicular |
1.204060E-03 |
| Classical-VS-Other |
3.224600E-01 |
| Classical-VS-Normal |
4.294400E-01 |
| Tall-VS-Follicular |
4.450800E-01 |
| Tall-VS-Other |
5.882000E-01 |
| Tall-VS-Normal |
4.229800E-04 |
| Follicular-VS-Other |
9.177200E-01 |
| Follicular-VS-Normal |
2.263100E-03 |
| Other-VS-Normal |
1.547650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.933960E-02 |
| Normal-vs-N1 |
3.657900E-02 |
| N0-vs-N1 |
5.929400E-01 |
|
|
